Author | Marks, Kristen M. | |
Author | Kang, Minhee | |
Author | Umbleja, Triin | |
Author | Avihingsanon, Anchalee | |
Author | Sugandhavesa, Patcharaphan | |
Author | Cox, Andrea L. | |
Author | Vigil, Karen | |
Author | Perazzo, Hugo | |
Author | Price, Jennifer C. | |
Author | Katsidzira, Leolin | |
Author | Vernon, Christina | |
Author | Alston-Smith, Beverly | |
Author | Sherman, Kenneth E. | |
Access date | 2024-03-13T00:08:35Z | |
Available date | 2024-03-13T00:08:35Z | |
Document date | 2023 | |
Citation | MARKS, Kristen M. et al. Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus. Clinical Infectious Diseases, v. 77, n. 3, p. 414-418, Aug. 2023. | en_US |
ISSN | 1058-4838 | en_US |
URI | https://www.arca.fiocruz.br/handle/icict/63029 | |
Description | Collaborators: ACTG 5379 Study Team: Oladapo Alli, Ceora Beijer, Stephanie Caruso, Mary Allegra Cermak, Shawn Chiambah, Lillian Collins, Kim Epperson, Francoise Giguel, Kevin Knowles, Jan Kosmyna, Michael Leonard, Philip Marzinek, Terence Mohammed, Sarah Zabih, Leonard Sowah, Randy Hyer. | en_US |
Language | eng | en_US |
Publisher | Oxford University Press | en_US |
Rights | restricted access | en_US |
Title | Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus | en_US |
Type | Article | en_US |
DOI | 10.1093/cid/ciad201 | |
Abstract | In this international, multicenter open-label study (ACTG A5379) of HepB-CpG vaccine in people with human immunodeficiency virus (HIV) without prior hepatitis B virus (HBV) vaccination, all 68 participants achieved HBV seroprotective titers after the 3-dose series in the primary analysis. No unexpected safety issues were observed. | en_US |
Affilliation | Division of Infectious Diseases. Weill Cornell Medicine. New York, New York, USA. | en_US |
Affilliation | Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research in the Department of Biostatistics. Boston, Massachusetts, USA. | en_US |
Affilliation | Harvard T. H. Chan School of Public Health. Center for Biostatistics in AIDS Research in the Department of Biostatistics. Boston, Massachusetts, USA. | en_US |
Affilliation | Chulalongkorn University. Faculty of Medicine. Thai Red Cross AIDS Research Centre and CE in Tuberculosis. HIV-NAT. Bangkok, Thailand. | en_US |
Affilliation | Chiang Mai University. Research Institute for Health Sciences. Chiang Mai, Thailand. | en_US |
Affilliation | Johns Hopkins University. Division of Infectious Diseases. Baltimore, Maryland, USA. | en_US |
Affilliation | University of Texas. McGovern Medical School, Houston. Division of Infectious Diseases.Texas, USA. | en_US |
Affilliation | Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Rio de Janeiro, RJ, Brazil. | en_US |
Affilliation | University of California San Francisco. Department of Medicine. Division of Gastroenterology and Hepatology. San Francisco, California, USA. | en_US |
Affilliation | University of Zimbabwe. Faculty of Medicine and Health Sciences. Internal Medicine Unit. Harare, Zimbabwe. | en_US |
Affilliation | DLH Corporation. Silver Spring, Maryland, USA. | en_US |
Affilliation | Division of AIDS. National Institute of Allergy and Infectious Diseases. National Institutes of Health. Bethesda, Maryland, USA. | en_US |
Affilliation | University of Cincinnati College of Medicine. Division of Digestive Diseases. Cincinnati, Ohio, USA. | en_US |
Subject | Hepatitis B | en_US |
Subject | Vaccine | en_US |
Subject | HIV | en_US |
Subject | HepB-CpG | en_US |
Subject | Heplisav-B | en_US |
e-ISSN | 1537-6591 | |
Embargo date | 2030-12-31 | |